Po‐Yuan Chang

1.3k total citations
43 papers, 1.0k citations indexed

About

Po‐Yuan Chang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Po‐Yuan Chang has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Surgery. Recurrent topics in Po‐Yuan Chang's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Po‐Yuan Chang is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Po‐Yuan Chang collaborates with scholars based in Taiwan, United States and Australia. Po‐Yuan Chang's co-authors include Shao‐Chun Lu, Chu‐Huang Chen, Shwu‐Fen Chang, Yuan-Teh Lee, Jyh‐Cheng Chen, Yun‐Wei Lin, Yuan‐Teh Lee, Jonathan Lu, Hao‐Yu Zheng and Chi‐Ming Lee and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Po‐Yuan Chang

38 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Yuan Chang Taiwan 21 329 284 251 188 129 43 1.0k
Cemile Koca Türkiye 20 498 1.5× 123 0.4× 233 0.9× 183 1.0× 87 0.7× 63 1.6k
Jing Liang China 18 295 0.9× 181 0.6× 109 0.4× 128 0.7× 94 0.7× 73 1.0k
S. Kapiotis Austria 18 249 0.8× 97 0.3× 198 0.8× 288 1.5× 97 0.8× 42 1.3k
Ting Yang China 19 586 1.8× 200 0.7× 228 0.9× 218 1.2× 105 0.8× 60 1.6k
I. Myara France 23 370 1.1× 264 0.9× 164 0.7× 119 0.6× 121 0.9× 60 1.5k
Órla P. Barry Ireland 14 965 2.9× 131 0.5× 337 1.3× 163 0.9× 229 1.8× 21 1.9k
Iryna Voloshyna United States 16 349 1.1× 306 1.1× 238 0.9× 134 0.7× 141 1.1× 34 1.1k
Mayra Domínguez‐Pérez Mexico 12 290 0.9× 180 0.6× 95 0.4× 207 1.1× 165 1.3× 19 927
María Miana Spain 22 477 1.4× 414 1.5× 448 1.8× 155 0.8× 463 3.6× 37 1.5k
Yu Jin Jung South Korea 19 434 1.3× 147 0.5× 150 0.6× 186 1.0× 120 0.9× 30 1.4k

Countries citing papers authored by Po‐Yuan Chang

Since Specialization
Citations

This map shows the geographic impact of Po‐Yuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Yuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Yuan Chang more than expected).

Fields of papers citing papers by Po‐Yuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Yuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Yuan Chang. The network helps show where Po‐Yuan Chang may publish in the future.

Co-authorship network of co-authors of Po‐Yuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Yuan Chang. A scholar is included among the top collaborators of Po‐Yuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Yuan Chang. Po‐Yuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Imae, Toyoko, et al.. (2025). Preparation of non-decolorizing fluorescent filaments and textiles from Ca-coagulated cellulose nanofibers. Journal of the Taiwan Institute of Chemical Engineers. 180. 106482–106482.
2.
Chen, Yi‐Ling, Ya‐Chi Ho, Po‐Yuan Chang, et al.. (2022). Diversity-Optimized Group Extraction in Social Networks. IEEE Transactions on Computational Social Systems. 11(1). 756–769. 2 indexed citations
3.
Chang, Po‐Yuan, et al.. (2021). Synergistic effects of electronegative-LDL- and palmitic-acid-triggered IL-1β production in macrophages via LOX-1- and voltage-gated-potassium-channel-dependent pathways. The Journal of Nutritional Biochemistry. 97. 108767–108767. 5 indexed citations
4.
Tseng, Fen‐Yu, Lung‐Chun Lin, Bor‐Sheng Ko, et al.. (2019). Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program. Journal of the Formosan Medical Association. 119(1). 538–543.
5.
Ho, Cheng‐Maw, Yung‐Ming Jeng, Yu-Sheng Lai, et al.. (2019). Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease. Journal of Inflammation. 16(1). 7–7. 66 indexed citations
6.
Chang, Christopher, et al.. (2018). Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study. BMC Cardiovascular Disorders. 18(1). 33–33. 13 indexed citations
7.
8.
Wei, Chia-Li, Jyh‐Cheng Chen, Hao‐Yu Zheng, et al.. (2016). Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells. Regulatory Toxicology and Pharmacology. 81. 353–361. 22 indexed citations
9.
Tung, Chun‐Liang, et al.. (2016). Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(6). 657–666. 23 indexed citations
10.
Lai, Yu‐Sheng, et al.. (2015). Electronegative LDL is linked to high-fat, high-cholesterol diet–induced nonalcoholic steatohepatitis in hamsters. The Journal of Nutritional Biochemistry. 30. 44–52. 26 indexed citations
11.
Ko, Jen‐Chung, Jyh‐Cheng Chen, Po‐Yuan Chang, et al.. (2015). Resveratrol Enhances Etoposide‐Induced Cytotoxicity through Down‐Regulating ERK1/2 and AKT‐Mediated X‐ray Repair Cross‐Complement Group 1 (XRCC1) Protein Expression in Human Non‐Small‐Cell Lung Cancer Cells. Basic & Clinical Pharmacology & Toxicology. 117(6). 383–391. 26 indexed citations
12.
Ko, Jen‐Chung, Po‐Yuan Chang, Jyh‐Cheng Chen, et al.. (2015). Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells. Biochemical Pharmacology. 97(3). 331–340. 8 indexed citations
13.
Chang, Shwu‐Fen, et al.. (2014). Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation. Journal of Biomedical Science. 21(1). 39 indexed citations
14.
Chang, Po‐Yuan, et al.. (2012). S-ADENOSYLHOMOCYSTEINE MEDIATES HOMOCYSTEINE ATHEROGENICITY BY SUPPRESSING THE FGF2-PROSURVIVAL PATHWAY IN ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 59(13). E430–E430.
15.
16.
Chang, Po‐Yuan, Karen Chang, Kai Chen, et al.. (2009). Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging. Journal of Biomedical Science. 16(1). 86–86. 45 indexed citations
17.
18.
Tang, Daming, Jonathan Lu, Jeffrey P. Walterscheid, et al.. (2007). Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. Journal of Lipid Research. 49(1). 33–47. 68 indexed citations
19.
Chang, Po‐Yuan, Shao‐Chun Lu, Ta‐Chen Su, et al.. (2004). Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. Journal of Lipid Research. 45(11). 2116–2122. 78 indexed citations
20.
Kopin, I J, et al.. (1990). Metabolic fate of injected radiolabelled dopamine and 2-fluorodopamine in rats. Neuropharmacology. 29(10). 881–887. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cemile Koca Breakdown of academic impact, for papers by Jing Liang Breakdown of academic impact, for papers by S. Kapiotis Breakdown of academic impact, for papers by Ting Yang Breakdown of academic impact, for papers by I. Myara Breakdown of academic impact, for papers by Órla P. Barry Breakdown of academic impact, for papers by Iryna Voloshyna Breakdown of academic impact, for papers by Mayra Domínguez‐Pérez Breakdown of academic impact, for papers by María Miana Breakdown of academic impact, for papers by Yu Jin Jung
Rankless by CCL
2026